LSX World Congress 2024

The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.
The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes.
LSX events connect life science decision makers with the capital, intelligence, innovation, and partners they need to grow their businesses and create the healthcare solutions of the future.
We’re excited to share that LSX has recently joined the Informa Connect Life Sciences family of platforms and products serving the Biopharma partnering and investment communities. Together we’ll be providing the Life Sciences community with even more connections and partnering opportunities across a broader geographical area, and with renewed focus on partnering for specific therapeutic areas and modalities.
Founded in 2014, LSX has grown a collection of partnering and strategy events that have played a crucial role in fundraising and M&A for global Biotech, Medtech and Healthtech companies. Now LSX comes into the Partnering portfolio of Informa Connect, operating as a sister company to both EBD, who deliver our flagship events Bio-Europe and Biotech Showcase, and partneringONE, the gold standard partnering software.
“The mission of our partnering portfolio has always been to facilitate strategic connections that drive life science dealmaking,” said Anna Chrisman, Managing Director of Informa Connect Life Sciences. “Now, our talented team has grown, and what we can offer the Life Sciences community has grown with it. We’re excited to welcome the LSX team and its suite of exclusive investment and partnering events to our portfolio, so we can curate even more highly relevant interactions among the leaders of our industry to help accelerate drug development.”
Matt Pullan and Josh Dance, who are leading the LSX team within Informa Connect as Co-Managing Directors, said: “This has been a fantastic opportunity to combine forces with the world’s leading producer of live events and benefit from the significant sector expertise, as well as their technology advantage. We’re excited about steering the business into the opportunities this move will bring for our clients and colleagues.”
Across the portfolio we will be delivering eight key events between now and the end of 2023, located in London, Denmark, Boston, North Carolina and Shanghai. Catch up with the teams on-site or reach out to your relationship manager to learn more. We look forward to seeing all our customers and clients in this critically important last quarter of the year.

When and Where